Entry into a Material Definitive Agreement

Business Context and Reporting Period

This Form 8-K Current Report was filed by Viewbix Inc. (not Quantum X Labs Inc.) on March 23, 2025, reporting events occurring on March 24, 2025. The registrant is a Delaware corporation headquartered in Tel Aviv, Israel. The filing primarily details the completion of a material acquisition.

Key Financial Metrics and Transaction Details

This filing does not contain standard financial statements (revenue, profit, cash flow, or margins) for the reporting period. The key financial metrics relate to the acquisition of Metagramm Software Ltd.:

  • Equity Issuance: Viewbix issued 1,323,000 shares of common stock to Metagramm shareholders.
  • Dilution Impact: The issuance represents 19.99% of Viewbix's issued and outstanding capital stock on a pro rata, post-closing basis.
  • Acquisition Target: 100% of Metagramm's issued and outstanding share capital (718,520 ordinary shares).
  • Cash Consideration: Potential earn-out payments of up to $2.0 million contingent on financing and revenue milestones over three years.
  • Escrow: Issued shares are held in escrow for 30 days pending a tax ruling from the Israeli Tax Authority.

Material Changes Versus Prior Period

The primary material change is the termination of a previous securities exchange agreement dated July 31, 2024, and its replacement with the new agreement executed on March 24, 2025. This transaction resulted in Metagramm becoming a wholly-owned subsidiary of Viewbix, significantly altering the company's capital structure through the issuance of nearly 20% of its equity.

Guidance, Outlook, and Risks

Management Commentary: The transaction was completed as of March 24, 2025. Future cash outflows are contingent on the achievement of specific financing and revenue milestones by the acquired subsidiary.

Risks and Contingencies:

  • Regulatory/Tax Risk: Issued shares are subject to a 30-day escrow period dependent on a tax ruling from the Israeli Tax Authority.
  • Performance Risk: The $2.0 million earn-out is not guaranteed and depends on future performance metrics.
  • Legal Limitations: Representations and warranties in the agreement are limited to the specific parties and dates of the agreement.

Investor Verification Checklist

  • Verify the exact number of outstanding shares prior to the transaction to confirm the 19.99% dilution calculation.
  • Review the specific financing and revenue milestones required to trigger the $2.0 million earn-out payments.
  • Confirm the status of the Israeli Tax Authority ruling to determine when the escrowed shares will be released.
  • Examine the full text of the Securities Exchange Agreement (Exhibit 10.1) for omitted schedules or specific covenants.
  • Clarify the discrepancy between the request metadata ("Quantum X Labs Inc.") and the filing registrant ("Viewbix Inc.").
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.